cinacalcet has been researched along with Diseases, Peripheral Vascular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, S; Chertow, GM; Montez-Rath, ME; Parfrey, PS | 1 |
| Chertow, GM; Kim, SM; Leonard, MB; Long, J; Montez-Rath, ME; Norton, JA | 1 |
| Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER | 1 |
1 trial(s) available for cinacalcet and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate | 2017 |
2 other study(ies) available for cinacalcet and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial.
Topics: Aged; Angina, Unstable; Calcimimetic Agents; Cause of Death; Cinacalcet; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cinacalcet; Female; Heart Failure; Hospital Mortality; Humans; Hyperparathyroidism, Secondary; Incidence; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Length of Stay; Male; Middle Aged; Parathyroidectomy; Peripheral Vascular Diseases; Treatment Outcome; United States; Young Adult | 2016 |